Ali Behbahani's Net Worth

$62.6 Thousand

Who is Ali Behbahani?

Ali Behbahani does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Nkarta, Inc., NeueHealth, Inc., Monte Rosa Therapeutics, Inc., Oyster Point Pharma, Inc., NEVRO CORP, Mirum Pharmaceuticals, Inc., Adaptimmune Therapeutics PLC, CRISPR Therapeutics AG, GENOCEA BIOSCIENCES, INC., Metacrine, Inc., CVRx, Inc., Arcellx, Inc., Savara Inc, Trevi Therapeutics, Inc., MINERVA SURGICAL INC, Akouos, Inc., Black Diamond Therapeutics, Inc., Arsanis, Inc., Regulus Therapeutics Inc., Marker Therapeutics, Inc., and Korro Bio, Inc..

SEC CIK

Ali Behbahani's CIK is 0001613867

Past Insider Trading and Trends

2021 was Ali Behbahani's most active year for acquiring shares with 23 total transactions. Ali Behbahani's most active month to acquire stocks was the month of May. 2021 was Ali Behbahani's most active year for disposing of shares, totalling 10 transactions. Ali Behbahani's most active month to dispose stocks was the month of September. 2022 saw Ali Behbahani paying a total of $168,748.48 for 903,630 shares, this is the most they've acquired in one year. In 2023 Ali Behbahani cashed out on 36,525 shares for a total of $0.00, their largest year based on trade value.